CAS RN: 472979-20-7
4-(2-AMINO-1,3-THIAZOL-4-YL)BENZENE-1,3-DIOLHYDROCHLORIDE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251124
100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 472979-20-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
472979-20-7 / 4-(2-amino-1,3-thiazol-4-yl)benzene-1,3-diol;hydrochloride
Standard CAS: 472979-20-7
Multi CAS: No
Basic Information
copy
CAS
472979-20-7 copy
Multi CAS
No copy
Molecular Formula
C9H9CLN2O2S copy
Molecular Weight
244.700000 copy
Exact Mass
244.007326 copy
InChI
InChI=1S/C9H8N2O2S.ClH/c10-9-11-7(4-14-9)6-2-1-5(12)3-8(6)13;/h1-4,12-13H,(H2,10,11);1H copy
InChIKey
IKZHBUBOEHGRCO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
11 copy
Rotatable bonds
1 copy
H-bond acceptors
5 copy
H-bond donors
3 copy
Molar refractivity
62.54 copy
TPSA
79.37 copy
LogP / Solubility
WLOGP
2.23 copy
MLOGP
1.96 copy
XLogP3
2.23 copy
Consensus LogP
2.14 copy
Log S (ESOL)
-3.24 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.17 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.22 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.63 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy